In the combined analysis of the XRCC1 and XPD allelic variants, the Kaplan-Meier survival curves showed differences in OS among the 4 allelic variants analyzed in stage II/III colon cancer patients (log-rank test P = 0.087, Figure 1a). The gene discussed is ERCC2; the disease is malignant colon neoplasm.